Wave Life Sciences. Every tracked FinTwit mention of $WVE, newest first. 12 mentions since the first on Sep 3, 2025. See the price chart.
March 2026 · 5 mentions
Mar 29
Adam Feuerstein ✡️ — @PeterKolchinsky Ok. I could draw up a similar list of targets, drug classes that never worked, despite a ton of time and money invested. You could, too. You invested heavily in $W…↗
Mar 29
Adam Feuerstein ✡️ — @PeterKolchinsky Peter - I could connect you with a fund manager who shorted $WVE. His thesis proved correct and profitable. He’s very smart. Great track record on the biotech shor…↗
Mar 26
Adam Feuerstein ✡️ — $WVE -40%. The stock price losing a lot more weight than its do-nothing "body composition" drug.
Remember...
https://t.co/XATxYYS3zB↗
Mar 26
Adam Feuerstein ✡️ — $WVE WVE-007 six-month data just released.... 1% placebo-adjusted weight loss! 🤣
https://t.co/DR0Au9V39m↗
Mar 12
Adam Feuerstein ✡️ — Doing some reading ahead of the next wave of $WVE INHBE "body composition" 🙄 data, smirking at the Jefferies analyst set up, which basically frames 6-month data as a win-win-win f…↗
February 2026 · 1 mention
Feb 2
Adam Feuerstein ✡️ — This is the Grade 5 SAE version of "our partner doesn't like or want our drug so they gave it back."
Wave Life Sciences $WVE announces plans to accelerate regulatory engagement wi…↗
January 2026 · 1 mention
Jan 6
Adam Feuerstein ✡️ — $ARWR another INHBE targeted drug with no weight loss.
Missing 24-week data
Miniscule Ns (and an omitted patient) in combo tirzepatide arm
But hey, who needs data when you can j…↗
December 2025 · 4 mentions
Dec 11
Adam Feuerstein ✡️ — In this week's Biotech Scorecard newsletter: $WVE
Wave’s ‘gym bro’ obesity drug is story over substance
https://t.co/XATxYYS3zB↗
Dec 8
Adam Feuerstein ✡️ — $2 billion of stock being offered tonight, collectively, from $GPCR $DYN $VERA $FULC $WVE $KYMR
and it's only 4:06 pm.↗
Dec 8
Adam Feuerstein ✡️ — $WVE We've entered the "patients are heavier is good!" phase of the obesity hype cycle.↗
Dec 8
Adam Feuerstein ✡️ — Happy Monday morning! Should be a busy one, with weekend ASH stock trading + $KYMR $DYN $GPCR $WVE data readouts.
And, of course, everyone will be buying more $ABVX